Increased Expression of DKK-1 in an Adynamic Bone Disease Model: Role of Phosphate

被引:0
|
作者
Truyts, Tania [1 ]
Ferreira, Juliana [1 ]
Neves, Katia [1 ]
Oliveira, Ivone [1 ]
Dominguez, Wagner [1 ]
Jorgetti, Vanda [1 ]
Moyses, Rosa [1 ]
dos Reis, Luciene [1 ]
机构
[1] Univ Sao Paulo, Lab Fisiopatol Renal, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, SP, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SUN-295
引用
收藏
页码:227 / 227
页数:1
相关论文
共 50 条
  • [21] Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
    Xiaoyi Dun
    Hua Jiang
    Jianfeng Zou
    Jun Shi
    Lili Zhou
    Rong Zhu
    Jian Hou
    Molecular Cancer, 9
  • [22] Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma
    Dun, Xiaoyi
    Jiang, Hua
    Zou, Jianfeng
    Shi, Jun
    Zhou, Lili
    Zhu, Rong
    Hou, Jian
    MOLECULAR CANCER, 2010, 9
  • [23] Source of serum Dkk-1 in breast cancer patients with bone metastases
    Journe, F.
    Kheddoumi, N.
    Voorzanger-Rousselot, N.
    Doriath, V.
    Garnero, P.
    Body, J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 40 - 41
  • [24] Dkk-1 inhibition increases bone mineral density in rodents.
    Grisanti, M.
    Niu, Q. T.
    Fan, W.
    Asuncion, F.
    Lee, J.
    Steavenson, S.
    Chen, Q.
    Li, J.
    Geng, Z.
    Kostenuik, P.
    Lacey, D. L.
    Simonet, W. S.
    Ominsky, M.
    Li, X.
    Richards, W. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S25 - S25
  • [25] Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
    Heiland, Gisela Ruiz
    Zwerina, Karin
    Baum, Wolfgang
    Kireva, Trayana
    Distler, Joerg H.
    Grisanti, Mario
    Asuncion, Frank
    Li, Xiadong
    Ominsky, Michael
    Richards, William
    Schett, Georg
    Zwerina, Jochen
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2152 - 2159
  • [26] DKK-1 in psoriatic arthritis: Correlation with disease activity and enthesopathy
    Wahba, Marian Aziz Wahba Abdo
    El-Gazzar, Nagat Mohamed
    Elsharaby, Radwa Mahmoud
    Tabra, Samar Abdalhamed
    REUMATOLOGIA CLINICA, 2024, 20 (01): : 14 - 19
  • [27] Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
    Chiarito, M.
    Piacente, L.
    Chaoul, N.
    Pontrelli, P.
    D'Amato, G.
    Grandone, A.
    Russo, G.
    Street, M. E.
    Wasniewska, M. G.
    Brunetti, G.
    Faienza, M. F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (06) : 1255 - 1263
  • [28] Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
    M. Chiarito
    L. Piacente
    N. Chaoul
    P. Pontrelli
    G. D’Amato
    A. Grandone
    G. Russo
    M. E. Street
    M. G. Wasniewska
    G. Brunetti
    M. F. Faienza
    Journal of Endocrinological Investigation, 2022, 45 : 1255 - 1263
  • [29] Lower Bone Mineral Density and alterations in bone biomarkers DKK-1, Sclerostin, and Periostin in individuals with Inflammatory Bowel Disease
    Palatianou, M.
    Tsentidis, C.
    Tzouvala, M.
    Papaconstantinou, I
    Vezakis, A.
    Gourgiotis, D.
    Marmarinos, A.
    Karamanolis, G.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i785 - i785
  • [30] Diagnostic reliability of DKK-1, sclerostin, sRANKL, osteopontin and periostin as markers for assessing the myeloma bone disease
    Gerova, D.
    Gerov, V.
    Micheva, I.
    Galunska, B.
    CLINICA CHIMICA ACTA, 2024, 558 : 89 - 89